Search Results

240 results for pvsa

PCSA Stock Earnings: Processa Pharma Misses EPS for Q2 2024

PCSA stock results show that Processa Pharma missed analyst estimates for earnings per share the second quarter of 2024.

ZVSA Stock Earnings: ZyVersa Therapeutics Beats EPS for Q2 2024

ZVSA stock results show that ZyVersa Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Why Is Processa Pharmaceuticals (PCSA) Stock Up 29% Today?

Processa Pharmaceuticals stock is up on Tuesday as PCSA investors react to approval for a Phase 2 clinical trial of NGC-Cap.

7 Safe Stocks to Pick Up Amid Incoming Uncertainty

The market is going through a shakeup in certain sectors. Now may be the time to consider compelling safe stocks to buy.

2U (TWOU) Stock Continues to Surge in Bankruptcy Rally

2U stock is up on Tuesday with heavy trading of TWOU shares as they continue to rally following a bankruptcy filing.

PSA Stock Earnings: Public Storage Beats EPS, Misses Revenue for Q2 2024

PSA stock results show that Public Storage beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

7 Energy Stocks to Buy for Their Game-Changing Potential

While advanced technologies command the spotlight, they also consume resources, bringing attention to energy stocks to buy.

Sure, Stellantis Can Bounce Back. But STLA Stock Is Still a Sell.

Stellantis delivered strong first-half results but Stellantis stock can easily bounce back over the longer term. 

7 Safe Stocks to Buy for Volatility Insurance

Although not known for their riveting narratives, these safe stocks to buy can offer protection amid a growth-sector shakedown.

Roaring Kitty vs. Risks: Why Investors Should Avoid GameStop Stock Now

Let’s dive into some potential outcomes for meme giant GameStop, and where shares of this video game retailer could be headed from here.

3 REITs to Buy for Dividend Yield AND Growth

These REITs to buy offer an alluring combo of safety, high yields, and dividend growth. They are perfect for income investors.

M&A News Pushes Two Bank Stocks to New Highs

Financial stocks are bouncing back, with Parkvale Financial and Southern Union Co. up against new highs. Tech stocks, on the other hand, are struggling.

Oil Refiners Holly Corp and Frontier Gush to New Highs

Crude oil refiner stocks Holly Corp and Frontier hit new 52 week highs today on merger and acquisition news.

7 REITs to Snap Up if the Fed Cuts Interest Rates

The New Norm: 7 Stocks to Buy for the Possibility of Permanent Inflation

Drill Rig Sinks Offshore of Venezuela (BP, RIG, STO, E)

Venezuelan President Hugo Chavez posted a message on Twitter this morning that a natural gas explosion in the Caribbean sank a semi-submersible drilling rig. The…

ZVSA Stock Earnings: ZyVersa Therapeutics Misses EPS for Q1 2024

ZVSA stock results show that ZyVersa Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

PCSA Stock Earnings: Processa Pharma Reported Results for Q1 2024

Processa Pharma just reported results for the first quarter of 2024.

Why Is ZyVersa Therapeutics (ZVSA) Stock Down 44% Today?

ZyVersa Therapeutics stock is falling hard on Thursday after the company priced a public offering for shares of ZVSA this morning.

Best Stocks 2022: Hard-Hit POSAF Stock Could Gain 10X From Here

POSaBIT has disappointed investors in 2022, but it is still one of the best stocks to buy. In fact, it could 10x to $5 by…

Best Stocks for 2022: Deep Value Tech Stock POSaBIT Is A Can’t Miss Cannabis Play

Risk-tolerant investors will find a lot to like about deep value cannabis fintech stock POSaBIT, which looks poised to ride converging tailwinds straight to the…

Best Stocks for 2022: POSaBIT Is a Top Penny Stock in a Bumpy Year

Investing in any penny stock comes with risks, but POSAF stock is a unique opportunity that could very well be 2022’s best penny stock.

POSAF Stock: My No. 1 Moonshot Pick for 2022

With limitations on many U.S. companies’ ability to deal in marijuana transactions, POSAF stock has a chance to grow substantially in 2022.

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 37% Today?

ZyVersa Therapeutics stock is rising higher on Monday as shares of ZVDA experience heavy pre-market trading this morning.

1 – 10 of 240 results